Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Delos Capital (Hong Kong)

Delos Capital (Hong Kong)?uq=PEM9b6PF
VC INVESTOR TYPE
Active STATUS
3 PROFESSIONALS
15 INVESTMENTS
13 PORTFOLIO
4 EXITS
Description

Delos Capital Partners is a healthcare-focused fund interested in funding and fostering the growth of science and technology across continents and cultures. The firm is interested in the development of drugs and medical devices that address unmet medical needs and enhance existing therapies by making them safer, improving efficacy and lowering costs. Delos is actively working hand-in-hand with the entrepreneurs to bring novel treatments and new devices to market - achieving global success in medicine. The fund's portfolio companies develop solutions in the areas of oncology, infectious diseases, cardiovascular diseases, ophthalmology, orthopedics and bariatrics. It plans to make investments through a broad variety of types and transaction structures, including early and late-stage developments, growth capital, direct or indirect private equity investments, buyout investments, strategic investments, restructurings and recapitalizations and investments in publicly listed securities.

Investor Status
Actively Seeking New Investments
Year Founded
2014
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
  • 401 Hutchison House
  • 10 Harcourt Road
  • Central
  • Hong Kong

+852 3912 0000

Delos Capital (Hong Kong) Investments (15)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Tulavi Therapeutics 03-Dec-2018 Early Stage VC 000 Other Healthcare Services Startup 00000 0000 00
000000 00000000000 27-Nov-2018 00000 00000 0000 Drug Discovery Startup 00000 0000 00
00 00000000000 19-Sep-2018 00000 00000 00000 Drug Discovery Generating Revenue 00000 0000 00
000000000 12-Jun-2018 00000 00000 000.00 Pharmaceuticals Generating Revenue 00000 0000 00
0000 0000000000000 06-Apr-2018 00000 00000 0000 Pharmaceuticals Generating Revenue 00000 0000 00
00000000000000 23-Jun-2017 00000 00000 0000 Other Business Products and Services Generating Revenue 00000 0000 00
000000000 000000 0 06-Mar-2017 00000 00000 0000 Therapeutic Devices Generating Revenue 00000 000000000000
0000000000000 03-Mar-2017 00000 00000 0000 Pharmaceuticals Startup 000-00 0000 00.0
Allecra Therapeutics 20-May-2016 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 3 00000 0000 00
Curatia 24-Nov-2015 Early Stage VC 000 Surgical Devices Startup 00000 0000 00
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Delos Capital (Hong Kong)’s full profile, request a free trial.

Delos Capital (Hong Kong) Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
Syndax 15-Mar-2018 Secondary Transaction - Open Market Completed
00000 0000000 16-Oct-2017 000000000000000000 00000 Completed
  • 000000 0000000000
Syndax 03-Mar-2016 IPO 000.00 Completed
Tanvex Biopharma 13-Aug-2015 IPO Completed
To view this investor’s complete exits history, request access »

Delos Capital (Hong Kong) Team (13)

Name Title Deals Funds Boards Office Contact
Info
Henry Chen JD Co-Founder & Managing Partner 00 0 0 Central, Hong Kong
Samuel Yin Ph.D Co-Founding Partner Central, Hong Kong
Lan-Bo Chen Ph.D Venture Partner 0 0 0 Central, Hong Kong
Frank Chen Co-Founding Partner Central, Hong Kong
Tim Xiao Principal 0 Central, Hong Kong

2 Former Team Members

You’re viewing 5 of 13 team members. Get the full list »

Delos Capital (Hong Kong) Co-Investors (37)

Name With Exits Lead Partner
Domain Associates 2 0
Lumira Ventures 0 0
Medvance Incubator Partners 0 0 0
ONSET Ventures 0 0 0
Forbion 0 0
To view this investor’s complete co-investor history, request access »